Abiopharma

🔍 Floyd H. Charles (Director)

Company: KOHLS Corp (KSS)

Report Date: 2026-06-24

Detailed Transactions and Holdings:

• Acquired 78 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 64,380.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 123 shares of Common Stock (Direct)
  Date: 2026-06-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 64,503.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: Award of additional deferred restricted stock units in lieu of $0.125 per share dividend issued by the Company on all common stock, which was payable on June 24, 2026. These units vest and will be settled on the same schedule as the underlying deferred restricted stock units.
• F2: Award of additional deferred restricted stock units in lieu of $0.125 per share dividend issued by the Company on all common stock, which was payable on June 24, 2026. These units will be settled on the same schedule as the underlying deferred restricted stock units.
• F3: Includes 11,954 unvested deferred restricted stock units.